IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Propanc Biopharma Inc

CUSIP: 74346N701 | 9 institutional holders

Quarters

Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

UBS Group AG182,614
0.0% of portfolio›$19.4K
Jane Street Group, LLC143,212
0.0% of portfolio›$15.2K
Marex Group Ltd67,724
0.0% of portfolio›$7.2K
Virtu Financial LLC40,748
0.0% of portfolio›$4
Sassicaia Capital Advisers LLC16,000
0.0% of portfolio›$1.7K
XTX Topco Ltd12,098
0.0% of portfolio›$1.3K
StyleTurnoverLocationFiled
UBS Group AG
182,614$19.4K0.0%CoreMediumZurich, Switzerland2026-05-05
Jane Street Group, LLC
143,212$15.2K0.0%CoreVery HighNew York, NY2026-05-12
Marex Group Ltd
67,724$7.2K0.0%Agg GrowthHighLondon, United Kingdom2026-05-13
Virtu Financial LLC
40,748$40.0%GARPVery HighNew York, NY2026-05-14
Sassicaia Capital Advisers LLC
16,000$1.7K0.0%Agg GrowthVery HighJericho, NY2026-05-13
XTX Topco Ltd
12,098$1.3K0.0%ValueVery HighLondon, United Kingdom2026-05-15